SCHEMBL4699400

SCHEMBL4699400

CCOC(=O)c1c(Cl)c2cc(C)cc(-c3ccccc3)c2[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.53
ALOX5 P09917 8/20 0.45
PTGES O14684 5/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 3/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 2/20 0.45
LMNA P02545 1/20 0.45
MAPK10 P53779 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
MAP3K5 Q99683 1/20 0.43
XBP1 P17861 1/20 0.43
GRM6 O15303 1/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4700724 0.83 PDE3B (0.49) CSF1RALOX5PTGESALDH1A1MEN1
SCHEMBL4696686 0.77 CSF1R (0.61) CSF1RALOX5PTGESALDH1A1HPGD
SCHEMBL13295306 0.75 CSF1R (0.58) CSF1RALOX5ALDH1A1HPGDMEN1
SCHEMBL1061379 0.74 KDM4E (0.64) CSF1RALOX5ALDH1A1MEN1KMT2A
SCHEMBL4700777 0.74 PDE3B (0.47) CSF1RALOX5PTGESALDH1A1MEN1
SCHEMBL9358714 0.74 ALOX5 (0.51) CSF1RALOX5PTGESALDH1A1HPGD
SCHEMBL14341981 0.73 CSF1R (0.53) CSF1RALOX5ALDH1A1HPGDMEN1
SCHEMBL13739817 0.72 CSF1R (0.52) CSF1RALDH1A1MEN1KMT2AKDM4E
SCHEMBL29611931 0.71 CSF1R (0.79) CSF1RALDH1A1HPGDMEN1KMT2A
SCHEMBL19952603 0.71 CSF1R (0.79) CSF1RALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996553-A2 TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES Avanir Pharmaceuticals (US) 2008-12-03 EP disclosed
WO-2007109251-A2 TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES AVANIR PHARMACEUTICALS (US) 2007-09-27 WO disclosed